EctoPharma
  • Home
  • ABOUT US
    • The Company – What we do
    • Business Model
    • Current Work
    • Who’s Who
    • In the Media
      • December 2010
      • September 2010
      • June 2010
      • December 2009
  • OUR PRODUCTS
    • KindaPed™
      • UK Launch of “Hedrin Treat & Go”
      • Properties of KindaPed™
      • Current Lice Treatments
      • Efficacy
      • Market Size
  • SHAREHOLDERS
    • Presentations
    • Letters
  • Contact us

Properties of KindaPed™

KindaPed™ is a market ready, topical anti-parasitic 1,2 octanediol lotion indicated for the eradication of head lice infestations.  Its primary site of action is the hair follicle.

  • Highly effective – 88% efficacy in Phase III study compared to 47% for existing market leading product.
  • Kills all stages in the head lice life-cycle (eggs, nymphs and adults) by dehydrating the waxy cuticle covering.
  • Formulated to kill lice in a single, easy to apply dose with rapid onset.
  • Non-toxic (already used in cosmetics)
  • Non-detectable on hair once dry – leaves no visible residue
  • Prevents egg laying
  • Helps prevent secondary scalp infections

 

 

Comments are closed.



KindaPed™

  • UK Launch of “Hedrin Treat & Go”
  • Properties of KindaPed™
  • Current Lice Treatments
  • Efficacy
  • Market Size
Go To Top »

Copyright Ectopharma 2011